- Home
- OABI vs RWAY Comparison
OABI vs RWAY Comparison
Compare OABI & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- RWAY
- Stock Information
- Founded
- OABI 2012
- RWAY 2015
- Country
- OABI United States
- RWAY United States
- Employees
- OABI N/A
- RWAY N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- OABI Health Care
- RWAY
- Exchange
- OABI Nasdaq
- RWAY Nasdaq
- Market Cap
- OABI 388.5M
- RWAY 390.5M
- IPO Year
- OABI N/A
- RWAY 2021
- Fundamental
- Price
- OABI $3.22
- RWAY $11.45
- Analyst Decision
- OABI Strong Buy
- RWAY Buy
- Analyst Count
- OABI 4
- RWAY 9
- Target Price
- OABI $9.00
- RWAY $11.82
- AVG Volume (30 Days)
- OABI 448.8K
- RWAY 426.6K
- Earning Date
- OABI 11-12-2024
- RWAY 03-06-2025
- Dividend Yield
- OABI N/A
- RWAY 3.48%
- EPS Growth
- OABI N/A
- RWAY N/A
- EPS
- OABI N/A
- RWAY 1.02
- Revenue
- OABI $20,409,000.00
- RWAY $150,078,000.00
- Revenue This Year
- OABI N/A
- RWAY N/A
- Revenue Next Year
- OABI $78.61
- RWAY N/A
- P/E Ratio
- OABI N/A
- RWAY $11.23
- Revenue Growth
- OABI N/A
- RWAY N/A
- 52 Week Low
- OABI $3.16
- RWAY $9.87
- 52 Week High
- OABI $6.55
- RWAY $13.74
- Technical
- Relative Strength Index (RSI)
- OABI 32.70
- RWAY 70.66
- Support Level
- OABI $3.16
- RWAY $10.78
- Resistance Level
- OABI $3.29
- RWAY $11.18
- Average True Range (ATR)
- OABI 0.13
- RWAY 0.16
- MACD
- OABI -0.02
- RWAY 0.04
- Stochastic Oscillator
- OABI 9.09
- RWAY 85.35
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.